GeoSymm Ventures v. CipherHealth: Voluntary Dismissal in Healthcare Communication Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | GeoSymm Ventures, LLC v. CipherHealth Inc. |
| Case Number | 1:24-cv-06232 (S.D.N.Y.) |
| Court | U.S. District Court for the Southern District of New York |
| Duration | Aug 2024 – Jan 2025 141 days |
| Outcome | Plaintiff Voluntary Dismissal |
| Patents at Issue | |
| Accused Products | CipherHealth’s “Assistive agent” product |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity (PAE) that pursued infringement claims based on its ownership of US9130900B2. PAEs monetize patent portfolios through licensing and litigation rather than commercial product development.
🛡️ Defendant
A New York-based healthcare technology company specializing in patient communication and care coordination solutions, whose “Assistive agent” product was identified in this litigation.
The Patent at Issue
At the center of the dispute was **U.S. Patent No. 9,130,900 B2** (Application No. 13/841,294), covering technology implicated in CipherHealth’s “Assistive agent” product.
- • US 9,130,900 B2 — Secure communication and network routing technology relevant to healthcare IT platforms.
Developing a healthcare communication product?
Check if your patient engagement platform might infringe this or related patents.
The Verdict & Legal Analysis
Outcome
This case was terminated via **plaintiff’s voluntary dismissal without prejudice**, pursuant to **Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure**. No damages were awarded, and no injunctive relief was granted or denied. No finding of infringement, validity, or invalidity was made.
Key Legal Issues
The pre-answer voluntary dismissal under Rule 41(a)(1)(A)(i) means no merits determination was reached. This procedural mechanism is frequently used in patent assertion contexts where pre-litigation negotiations reach resolution, plaintiffs reassess claim strength, or business/strategic decisions shift priorities.
Filing patents for healthcare IT?
Learn from this case. Use AI to draft stronger claims that can withstand litigation.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in healthcare communication. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View related patent families and prior art
- See which companies are most active in healthcare communication patents
- Understand assertion strategies in early-stage dismissals
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Network communication & assistive agent platforms
1 Patent at Issue
US 9,130,900 B2
Early Dismissal
Common in PAE cases
✅ Key Takeaways
For Patent Attorneys & Litigators
Pre-answer voluntary dismissal under Rule 41(a)(1)(A)(i) forecloses fee-shifting claims by defendants.
Search related case law →NPE cases in S.D.N.Y. often resolve before merits briefing; early case assessment and rapid invalidity positioning matter disproportionately.
Explore precedents →Without a stipulation specifying “with prejudice,” dismissed claims remain live — monitor for refiling.
View Rule 41 guidance →For IP Professionals & R&D Teams
Track patent families related to US9130900B2 for continuation or divisional applications that may support future assertions.
Start FTO analysis for my product →Healthcare IT companies should maintain updated FTO analyses as communication platform patents are actively asserted.
Try AI patent drafting →Network communication and assistive agent technology remains a high-assertion-risk area; design-around analysis and prior art documentation are essential risk management tools.
Request expert FTO consultation →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.